Obese and Non-obese Polycystic Ovarian Syndrome: Comparison of Clinical, Metabolic, Hormonal Parameters, and their Differential Response to Clomiphene.

Garima Sachdeva,Shalini Gainder,Vanita Suri,Naresh Sachdeva,Seema Chopra

Indian journal of endocrinology and metabolism（2019）

引用 15|浏览3

暂无评分

摘要

Obese PCOS have a higher risk of adverse outcomes like hypertension, IR, metabolic syndrome, and endometrial hyperplasia. So, targeting obesity in PCOS women will not only help to prevent adverse outcomes but also improve responsiveness to clomiphene citrate.

查看译文

关键词

Body mass index,hypertension clomiphene,metabolic syndrome,polycystic ovarian syndrome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要